MedTrace Logo

Reduction of the Glycemic Index by a Novel Viscous Polysaccharide

NCT00935350 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2009-07-09

No results posted yet for this study

Summary

Reductions of postprandial glucose levels have been demonstrated previously with the addition of a novel viscous polysaccharide (NVP) to a glucose drink and standard white bread. This study explores whether these reductions are sustained when NVP is added to a range of commonly consumed foods.

Conditions

  • Blood Glucose, Postprandial

Interventions

DIETARY_SUPPLEMENT

PolyGlycopleX (PGX)

2.5 grams of PGX

DIETARY_SUPPLEMENT

PolyGlycopleX (PGX)

5.0 grams of PGX

DIETARY_SUPPLEMENT

PolyGlycopleX (PGX)

0 grams of PGX

Sponsors & Collaborators

  • InovoBiologic Inc.

    collaborator INDUSTRY

  • Canadian Center for Functional Medicine

    collaborator OTHER

  • Glycemic Index Laboratories, Inc

    lead INDUSTRY

Principal Investigators

  • Alexandra L Jenkins, PhD, RD · Glycemic Index Laboratories, Inc

  • Thomas MS Wolever, MD · Glycemic Index Laboratories, Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2006-06-30
Completion
2006-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00935350 on ClinicalTrials.gov